Personal information

Emails & domains

Verified email domains

Activities

Collapse all

Works (5)

Lentiviral vectors for precise expression to treat X-linked lymphoproliferative disease

Molecular Therapy - Methods & Clinical Development
2024-12 | Journal article
DOI: 10.1016/j.omtm.2024.101323
Part of ISSN: 2329-0501
Contributors: Paul G. Ayoub; Julia Gensheimer; Lindsay Lathrop; Colin Juett; Jason Quintos; Kevin Tam; Jack Reid; Feiyang Ma; Curtis Tam; Grace E. McAuley et al.
Source: Self-asserted source
Jason Patrick Quintos

Lentiviral gene therapy for X-linked chronic granulomatous disease recapitulates endogenous CYBB regulation and expression

Blood
2023-03-02 | Journal article
DOI: 10.1182/blood.2022016074
Contributors: Ryan L. Wong; Sarah Sackey; Devin Brown; Shantha Senadheera; Katelyn Masiuk; Jason P. Quintos; Nicole Colindres; Luke Riggan; Richard A. Morgan; Harry L. Malech et al.
Source: check_circle
Crossref

Improved SARS-CoV-2 Spike Glycoproteins for Pseudotyping Lentiviral Vectors

Frontiers in Virology
2021-11-26 | Journal article
DOI: 10.3389/fviro.2021.793320
Part of ISSN: 2673-818X
Contributors: Jason Patrick Quintos; Paul G. Ayoub; Arunima Purkayastha; Jason Quintos; Curtis Tam; Lindsay Lathrop; Kevin Tam; Marlene Ruiz; Roger P. Hollis; Brigitte N. Gomperts et al.
Source: Self-asserted source
Jason Patrick Quintos

β-Globin Lentiviral Vectors Have Reduced Titers due to Incomplete Vector RNA Genomes and Lowered Virion Production

Stem Cell Reports
2020-11 | Journal article
DOI: 10.1016/j.stemcr.2020.10.007
Part of ISSN: 2213-6711
Source: Self-asserted source
Jason Patrick Quintos

Improved Titer and Gene Transfer by Lentiviral Vectors Using Novel, Small β-Globin Locus Control Region Elements

Molecular Therapy
2020-01 | Journal article
DOI: 10.1016/j.ymthe.2019.09.020
Part of ISSN: 1525-0016
Source: Self-asserted source
Jason Patrick Quintos
How many people are using ORCID?